0

Nephrology Collection
 201-220 of 2266 Articles
Articles |  21 January 2003
Pravastatin for Secondary Prevention of Cardiovascular Events in Persons with Mild Chronic Renal Insufficiency
Marcello Tonelli, MD, SM; Lemuel Moyé, MD, PhD; Frank M. Sacks, MD; et al.
Ann Intern Med. 2003;138(2):98-104. doi:10.7326/0003-4819-138-2-200301210-00010
Reviews |  5 November 2002
Diagnosis and Treatment of Acute Tubular Necrosis
Matthew L. Esson, MD; Robert W. Schrier, MD
Ann Intern Med. 2002;137(9):744-752. doi:10.7326/0003-4819-137-9-200211050-00010
Articles |  1 October 2002 FREE
Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients
Michael G. Shlipak, MD, MPH; Paul A. Heidenreich, MD, MS; Haruko Noguchi, PhD; et al.
Ann Intern Med. 2002;137(7):555-562. doi:10.7326/0003-4819-137-7-200210010-00006
Articles |  1 October 2002
Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination
R. Scott Wright, MD; Guy S. Reeder, MD; Charles A. Herzog, MD; et al.
Ann Intern Med. 2002;137(7):563-570. doi:10.7326/0003-4819-137-7-200210010-00007
Ideas and Opinions |  1 October 2002
In Memoriam: J. Russell Elkinton, MD, MACP, FRCP(L); 1910–2002; Editor, Annals of Internal Medicine, 1960–1971
Edward J. Huth, MD, Editor Emeritus
Ann Intern Med. 2002;137(7):613-614. doi:10.7326/0003-4819-137-7-200210010-00013
Editorials |  1 October 2002
Cardiac Mortality in Chronic Kidney Disease: A Clearer Perspective
Raymond R. Townsend, MD
Ann Intern Med. 2002;137(7):615-616. doi:10.7326/0003-4819-137-7-200210010-00014
Articles |  17 September 2002
The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality
Kraig S. Kinchen, MD, MSc; John Sadler, MD; Nancy Fink, MPH; et al.
Ann Intern Med. 2002;137(6):479-486. doi:10.7326/0003-4819-137-6-200209170-00007
Editorials |  17 September 2002
Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late
Norman G. Levinsky, MD
Ann Intern Med. 2002;137(6):542-543. doi:10.7326/0003-4819-137-6-200209170-00016
Articles |  3 September 2002
Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial
Barry R. Davis, MD, PhD; Jeffrey A. Cutler, MD; Curt D. Furberg, MD, PhD; et al.
Ann Intern Med. 2002;137(5_Part_1):313-320. doi:10.7326/0003-4819-137-5_Part_1-200209030-00006
Editorials |  16 July 2002
Indwelling Urinary Catheters: A One-Point Restraint?
Sanjay Saint, MD, MPH; Benjamin A. Lipsky, MD; Susan Dorr Goold, MD, MHSA, MA
Ann Intern Med. 2002;137(2):125-127. doi:10.7326/0003-4819-137-2-200207160-00012
Articles |  2 July 2002
Reporting the Recruitment Process in Clinical Trials: Who Are These Patients and How Did They Get There?
Cary P. Gross, MD; Raburn Mallory, MD; Asefeh Heiat, MD; et al.
Ann Intern Med. 2002;137(1):10-16. doi:10.7326/0003-4819-137-1-200207020-00007
Articles |  18 June 2002
The Ankle Brachial Index Is Associated with Leg Function and Physical Activity: The Walking and Leg Circulation Study
Mary McGrae McDermott, MD; Philip Greenland, MD; Kiang Liu, PhD; et al.
Ann Intern Med. 2002;136(12):873-883. doi:10.7326/0003-4819-136-12-200206180-00008
Academia and the Profession |  4 June 2002
The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance?
Ted J. Kaptchuk, OMD
Ann Intern Med. 2002;136(11):817-825. doi:10.7326/0003-4819-136-11-200206040-00011
Articles |  7 May 2002
Public Expectations and Attitudes for Annual Physical Examinations and Testing
Sylvia K. Oboler, MD; Allan V. Prochazka, MD, MSc; Ralph Gonzales, MD, MPH; et al.
Ann Intern Med. 2002;136(9):652-659. doi:10.7326/0003-4819-136-9-200205070-00007
Therapeutics |  May/Jun 2002
Irbesartan was renoprotective in patients with type 2 diabetes, hypertension, and microalbuminuria
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):82. doi:10.7326/ACPJC-2002-136-3-082
Therapeutics |  May/Jun 2002
Irbesartan reduced progression of nephropathy caused by type 2 diabetes independent of the effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):83. doi:10.7326/ACPJC-2002-136-3-083
Therapeutics |  May/Jun 2002
Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure
Christian G. Rabbat, MD
Ann Intern Med. 2002;136(3):84. doi:10.7326/ACPJC-2002-136-3-084
Therapeutics |  May/Jun 2002
Review: Recombinant human erythropoietin decreases the need for blood transfusions and may delay dialysis in chronic renal failure
Steven Fishbane, MD
Ann Intern Med. 2002;136(3):85. doi:10.7326/ACPJC-2002-136-3-085
Reviews |  16 April 2002
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
Giuseppe Remuzzi, MD; Piero Ruggenenti, MD; Norberto Perico, MD
Ann Intern Med. 2002;136(8):604-615. doi:10.7326/0003-4819-136-8-200204160-00010
Articles |  2 April 2002
Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials
Seamus P. Whelton; Ashley Chin, MPH, MA; Xue Xin, MD, MS; et al.
Ann Intern Med. 2002;136(7):493-503. doi:10.7326/0003-4819-136-7-200204020-00006
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)